Faeth Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $-4,851 |
Gross Profit | -132,957 | |||
EBITDA | -15,982 | -170,206 | -4,680 | -4,529 |
EBIT | -16,007 | -170,236 | -4,714 | -4,563 |
Net Income | -16,007 | -170,236 | -4,717 | -4,569 |
Net Change In Cash | 0 | 0 | 0 | -4,851 |
Free Cash Flow | -15,673 | -10,739 | -3,864 | -3,586 |
Cash | 26,903 | 152,325 | 8,668 | 10,562 |
Basic Shares | 5,643 | 1,295 | 1,261 | 1,261 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -551 | -571 | -1,808 | |
EBITDA | -20,914 | -29,516 | -33,386 | -46,561 |
EBIT | -21,053 | -30,067 | -37,064 | -48,369 |
Net Income | -21,085 | -30,157 | -34,101 | -48,588 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -20,469 | -24,816 | -32,203 | -39,347 |
Cash | 8,668 | 9,994 | 13,011 | 17,795 |
Basic Shares | 1,260 | 1,255 | 1,397 | 1,535 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$2.84 |
2026-03-31 | -$131.45 |
2025-12-31 | -$3.74 |
2025-09-30 | -$3.62 |